Involvement of 4E-BP1 in the protection induced by HDLs on pancreatic beta-cells

Mol Endocrinol. 2009 Oct;23(10):1572-86. doi: 10.1210/me.2008-0448. Epub 2009 Jul 2.

Abstract

High-density lipoproteins (HDLs) protect pancreatic beta-cells against apoptosis. This property might relate to the increased risk to develop diabetes in patients with low HDL blood levels. However, the mechanisms by which HDLs protect beta-cells are poorly characterized. Here we used a transcriptomic approach to identify genes differentially modulated by HDLs in beta-cells subjected to apoptotic stimuli. The transcript encoding 4E-binding protein (4E-BP)1 was up-regulated by serum starvation, and HDLs blocked this increase. 4E-BP1 inhibits cap-dependent translation in its non- or hypophosphorylated state but it loses this ability when hyperphosphorylated. At the protein level, 4E-BP1 was also up-regulated in response to starvation and IL-1beta, and this was blunted by HDLs. Whereas an ectopic increase of 4E-BP1 expression induced beta-cell death, silencing 4E-BP1 increase with short hairpin RNAs inhibited the apoptotic-inducing capacities of starvation. HDLs can therefore protect beta-cells by blocking 4E-BP1 protein expression, but this is not the sole protective mechanism activated by HDLs. Indeed, HDLs blocked apoptosis induced by endoplasmic reticulum stress with no associated decrease in total 4E-BP1 induction. Although, HDLs favored the phosphorylation, and hence the inactivation of 4E-BP1 in these conditions, this appeared not to be required for HDL protection. Our results indicate that HDLs can protect beta-cells through modulation of 4E-BP1 depending on the type of stress stimuli.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism*
  • Amino Acids / metabolism
  • Animals
  • Apoptosis / drug effects
  • Biomarkers / metabolism
  • Carrier Proteins / metabolism*
  • Cell Cycle Proteins
  • Cell Line, Tumor
  • Cholesterol / biosynthesis
  • Cytoprotection / drug effects*
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / genetics
  • Endoplasmic Reticulum / pathology
  • Eukaryotic Initiation Factors
  • Gene Expression Regulation / drug effects
  • Humans
  • Insulin-Secreting Cells / cytology*
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / metabolism*
  • Interleukin-1beta / pharmacology
  • Lipoproteins, HDL / pharmacology*
  • Mice
  • NF-kappa B / metabolism
  • Oligonucleotide Array Sequence Analysis
  • Phosphoproteins / metabolism*
  • Protein Biosynthesis / drug effects
  • Serum
  • Stress, Physiological / drug effects

Substances

  • Adaptor Proteins, Signal Transducing
  • Amino Acids
  • Biomarkers
  • Carrier Proteins
  • Cell Cycle Proteins
  • EIF4EBP1 protein, human
  • Eif4ebp1 protein, mouse
  • Eukaryotic Initiation Factors
  • Interleukin-1beta
  • Lipoproteins, HDL
  • NF-kappa B
  • Phosphoproteins
  • Cholesterol